Compare AbCellera Biologics Inc (ABCL) vs AFLAC Incorporated (AFL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs AFLAC Incorporated — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while AFLAC Incorporated trades at $121.06 (market cap $60.70B). The key difference: AFLAC Incorporated is far larger — about 20.3× AbCellera Biologics Inc's market cap, and AFLAC Incorporated pays a 2.02% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | AFL | |
|---|---|---|
Market Cap | $2.99B | $60.70B |
Sector | Health | Financials |
52-Week High | $9.76 | $129.55 |
52-Week Low | $2.78 | $103.55 |
Enterprise Value | $2.58B | $70.65B |
Dividend Yield | — | 2.02% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →
